Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event?
Hepatic artery thrombosis (HAT) is one of the most serious complications after orthotopic liver transplantation, and is associated with a high morbidity and mortality. This study retrospectively reviewed 66 liver transplants in children under the age of 10 years during a year-long period at a single institution. A total of 28 perioperative variables were analyzed to identify responsible factors of HAT. Of the 66 children, 18 (26%) developed HAT within 15 days after the transplant (HAT group); 29 (42%) had an uneventful postoperative course (control group). To avoid the possible influence of other complications 19 patients were excluded. Of the variables compared between the 2 study groups, three surgical factors (diameter of the hepatic artery--greater or less than 3 mm; type of arterial anastomosis--end-to-end versus the use of an iliac graft or aortic conduit; and number of times the anastomosis was redone--one versus more than one), were found to be significantly different (P less than .05) between HAT and control groups. Two medical factors also were significantly different: the use of intraoperative transfusion of fresh frozen plasma (FFP) and the administration of postoperative prophylactic anticoagulant treatment. A heparin and dextran-40 protocol appeared to be effective in preventing HAT (P less than .02). Moreover, after multivariate analysis, anticoagulation therapy was demonstrated to be the major independent variable influencing HAT. A better definition of factors responsible for the occurrence of HAT is required. This study should help in formulating effective methods to decrease the incidence of this dreaded complication after liver transplantation.
Mazzaferro
V
V
The Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15213.
Esquivel
C O
CO
Makowka
L
L
Belle
S
S
Kahn
D
D
Koneru
B
B
Scantlebury
V P
VP
Stieber
A C
AC
Todo
S
S
Tzakis
A G
AG
D000714:Anastomosis, Surgical / Q000009:adverse effects / Q000379:methods; D001241:Aspirin / Q000009:adverse effects; D001780:Blood Coagulation Tests; D002445:Celiac Artery / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D003911:Dextrans / Q000009:adverse effects; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006499:Hepatic Artery / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007431:Intraoperative Complications / Q000097:blood / Q000209:etiology; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000209:etiology* / Q000503:physiopathology
D003911:Dextrans; D006493:Heparin; D001241:Aspirin